Related Experiment Videos

Bacterial collagenase. Proposed adjunct to vitrectomy with membranectomy

Insights

Clostridiopeptidase A effectively digested preretinal scar tissue in rabbits without harming the retina. Prompt removal via vitrectomy ensured normal retinal function and morphology, suggesting a novel approach for vitrectomy.

Area of Science:

  • Ophthalmology
  • Enzyme therapy
  • Retinal surgery

Background:

  • Preretinal scarring can impair vision and complicate vitreoretinal surgery.
  • Current surgical techniques for scar removal carry risks of retinal damage.

Purpose of the Study:

  • To evaluate the efficacy and safety of Clostridiopeptidase A (collagenase) for digesting preretinal scar tissue.
  • To assess the enzyme's impact on retinal structures and function.

Main Methods:

  • Enzymatic digestion of preretinal cicatricial tissue in rabbit eyes using purified Clostridiopeptidase A.
  • Light and transmission electron microscopy to examine retinal morphology.
  • Assessment of retinal function via electroretinograms post-vitrectomy.

Main Results:

  • Clostridiopeptidase A digested preretinal scar tissue within 30 minutes without altering normal retinal morphology.
  • Enzyme removal by vitrectomy at 48 hours post-injection resulted in normal electroretinograms and retinal structure.
  • Prolonged enzyme exposure (24 hours) led to adverse effects including lens opacities and hemorrhage.

Conclusions:

  • Purified Clostridiopeptidase A demonstrates specific collagenase activity against vitreal scar tissue.
  • This enzyme holds potential as a novel adjunct to vitrectomy for scar removal, minimizing retinal damage.

Related Concept Videos